Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Sodium Valproate 200mg + Valproic Acid 87mg Tablet
Therapeutic Category
Neurology, Antiepileptic
Dosage Form
Tablet
Packaging Type
Alu Strip
Packaging
10*10
Price
₹69.55/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Sodium Valproate 200mg + Valproic Acid 87mg tablet is a broad-spectrum antiepileptic formulation used for the effective management of seizure disorders and epilepsy.
It works by stabilizing neuronal membranes and increasing GABA levels in the brain, thereby preventing abnormal electrical discharges and reducing the frequency and severity of seizures.
This tablet is commonly prescribed for generalized and partial seizures, bipolar disorder management, and migraine prophylaxis, providing comprehensive neurological support.
With strong clinical efficacy, proven safety profile, and high prescription acceptance, this formulation enhances a neurology-focused product range and supports consistent therapeutic demand.
Common side effects may include nausea, vomiting, dizziness, tremors, weight gain, or mild gastrointestinal discomfort. Rarely, liver dysfunction or thrombocytopenia may occur; regular monitoring is advised.
Valpotime CR 300 Tablet is indicated for the management of epilepsy, including generalized and partial seizures, bipolar disorder, and migraine prophylaxis, as prescribed by a healthcare professional.
For oral use only. Use strictly under medical supervision. Do not discontinue abruptly without consulting a physician. Inform your doctor of any liver, kidney, or metabolic disorders prior to use.
Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.
Composition : Calcium Dobesilate Monohydrate I.P. 0.5% w/w + Lignocaine Hydrochloride I.P. 3% w/w + Hydrocortisone Acetate I.P. 0.25% w/w + Zinc Oxide I.P. 5% w/w
Composition : Chlorhexidine Gluconate (0.20% w/w) + Silver Nitrate (0.20% w/w) cream
Composition : Silver Sulfadiazine (1%) + Chlorhexidine Gluconate (0.2%) + Metronidazole (1%) Cream
Composition : Clindamycin (1% w/w)Gel
Composition : Clindamycin 1 % w/w + Niacinamide 4 % w/w Gel
Composition : Clobetasol Propionate I.P. 0.05%w/w
Composition : Beclometasone (0.025% w/v) + Clotrimazole (1% w/v) lotion
Composition : Ofloxacin I.P. 0.75% w/w + Ornidazole I.P. 2.0% w/w + Itraconazole B.P. 1.0% w/w + Clobetasol Propionate I.P. 0.05% w/w + Methylparaben I.P. 0.2% w/w + Propylparaben I.P. 0.02% w/w Cream
Composition : Metronidazole (1% w/w) + Sucralfate (7% w/w) + Povidone Iodine (5% w/w)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Valpotime CR 300 Tablet has strong demand in the neurology, psychiatry, and central nervous system (CNS) segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on neurological and mental healthcare portfolios.
Medical distributors and agencies can benefit from consistent demand for neurological and mood disorder management under specialist supervision. Sodium Valproate 200mg + Valproic Acid 87mg (Controlled Release) is a well-established anticonvulsant and mood-stabilizing combination Commonly prescribed for the management of epilepsy, seizure disorders, bipolar disorder, and migraine prophylaxis as advised by healthcare professionals Controlled-release formulation helps provide sustained drug release and supports long-term treatment adherence Helps control abnormal electrical activity in the brain and assists in maintaining neurological stability Frequently utilized in neurology clinics, psychiatry centers, hospitals, and specialty healthcare facilities Requires regular medical monitoring and dosage adjustment as determined by healthcare professionals Widely prescribed by neurologists and psychiatrists This strengthens a comprehensive CNS and neurological care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Valpotime CR 300 Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers
Wholesalers and medical agencies benefit from strong prescription demand, long-term therapy requirements, repeat purchases, reliable supply chain support, and attractive margins in the neurology and psychiatry segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.